Endovascular Repair of Aortic Dissection in Marfan Syndrome: Current Status and Future Perspectives.

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science (2006) 10.25

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med (2008) 7.31

The revised Ghent nosology for the Marfan syndrome. J Med Genet (2010) 6.87

2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.75

Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med (1994) 5.03

Marfan's syndrome. Lancet (2005) 4.99

Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med (1999) 4.17

Life expectancy and causes of death in the Marfan syndrome. N Engl J Med (1972) 3.78

Life expectancy in the Marfan syndrome. Am J Cardiol (1995) 3.14

Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg (2008) 3.04

Retrograde ascending aortic dissection during or after thoracic aortic stent graft placement: insight from the European registry on endovascular aortic repair complications. Circulation (2009) 2.74

Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol (2013) 2.24

Thoracic aortic endografting in patients with connective tissue diseases. J Endovasc Ther (2008) 1.74

Stent graft-induced new entry after endovascular repair for Stanford type B aortic dissection. J Vasc Surg (2010) 1.62

Open repair of thoracoabdominal aortic aneurysm in the modern surgical era: contemporary outcomes in 509 patients. J Am Coll Surg (2011) 1.59

Distal aortic reinterventions after root surgery in Marfan patients. Ann Thorac Surg (2008) 1.56

Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease a systematic review and meta-analysis of comparative studies. J Am Coll Cardiol (2010) 1.53

Retrograde type A aortic dissection after endovascular stent graft placement for treatment of type B dissection. Circulation (2009) 1.33

Endovascular treatment of acute and chronic aortic pathology in patients with Marfan syndrome. J Vasc Surg (2012) 1.32

Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg (2012) 1.04

Endovascular management of chronic aortic dissection in patients with Marfan syndrome. J Vasc Surg (2009) 0.94

Treating the thoracic aorta in Marfan syndrome: surgery or TEVAR? J Endovasc Ther (2009) 0.94

Marfan syndrome: 30 years of research equals 30 years of additional life expectancy. Heart (2008) 0.92

Stent grafting of dissected descending aorta in patients with Marfan's syndrome: mid-term results. JACC Cardiovasc Interv (2008) 0.92

Stent graft repair of descending aortic dissection in patients with Marfan syndrome: an effective alternative to open reoperation? J Thorac Cardiovasc Surg (2009) 0.88

Marfan syndrome: from gene to therapy. Curr Opin Pediatr (2012) 0.87

Stent-grafts in patients with marfan syndrome. J Endovasc Ther (2005) 0.87

Presentation and outcome of Marfan's syndrome patients with dissection and thoraco-abdominal aortic aneurysm. Eur J Cardiothorac Surg (2007) 0.83

Endovascular treatment of type B dissection in patients with Marfan syndrome: mid-term outcomes and aortic remodeling. Catheter Cardiovasc Interv (2013) 0.77